Figure 3
High fascin expression correlates with a clinically aggressive tumor phenotype. The Kaplan-Meier survival curves show that stage III and IV patients with highly fascin-positive adenocarcinomas had decreased survival compared to patients with fascin-low or -negative tumors (significant at p = 0.023).